Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens

Cancer Research

Volumn 67, Issue 8, 2007, Pages 3904-3911

  Doak, Shareen H ^a   Jenkins, Gareth J S ^a   Johnson, George E ^a   Quick, Emma ^a   Parry, Elizabeth M ^a   Parry, James M ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CARCINOGEN; DNA; ETHYLNITROSOUREA; HYPOXANTHINE; MESYLIC ACID ETHYL ESTER; MESYLIC ACID METHYL ESTER; METHYLNITROSOUREA; PHOSPHORIBOSYLTRANSFERASE;

ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME DAMAGE; CONTROLLED STUDY; DNA ADDUCT; GENE FREQUENCY; GENE MUTATION; GENE TARGETING; HOMEOSTASIS; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; MICRONUCLEUS; PRIORITY JOURNAL;

ALKYLATING AGENTS; CELL LINE; CHROMOSOME ABERRATIONS; DNA; DNA ADDUCTS; DNA DAMAGE; ETHYL METHANESULFONATE; ETHYLNITROSOUREA; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LYMPHOCYTES; METHYL METHANESULFONATE; METHYLNITROSOUREA; MUTAGENS; POINT MUTATION;

EID: 34248577471     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-4061     Document Type: Article

References (38)

1. Henderson L, Albertini S, Aardema M. Thresholds in genotoxicity responses. Mut Res 2000;464:123-8.
2. Knudson AG. Mutation and cancer. A statistical study of retinoblastoma PNAS 1971;68:820-3.
3. Elhajouji A, Van Hummelen P, Kirsch-Volders M. Indications for a threshold of chemically induced aneuploidy in vitro in human lymphocytes. Environ Mol Mutat 1995;26:292-304.
4. Lynch A, Harvey J, Aylott M, et al. Investigations into the concept of a threshold for topoisomerase inhibitor-induced clastogenicity. Mutagenesis 2003;18: 345-53.
5. Elhajouji A, Tibaldi F, Kirsch-Volders M. Indication for thresholds of chromosome non-disjunction versus chromosome lagging induced by spindle inhibitors in vitro in human lymphocytes. Mutagenesis 1997;12: 133-40.
6. Parry JM, Fielder RJ, McDonald A. Thresholds for aneuploidy-inducing chemicals. Mutagenesis 1994;9: 503-4.
7. Parry JM, Jenkins GJS, Haddad R, Bourner R, Parry EM. In vitro and in vivo extrapolations of genotoxin exposure: consideration of factors which influence dose-response thresholds. Mut Res 2000; 464:53-63.
8. Hensley MS, Schuchter LM, Lindley C. et al. American Society of clinical oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol 1999;17:3333-5.
9. Drablos F, Feyzi E, Aas PA, et al. Alkylation damage in DNA and RNA - repair mechanisms and medical significance. DNA Repair 2004;3:1389-407.
10. Farmer PB, Sepai O, Lawrence R, et al. Biomonitoring human exposure to environmental carcinogenic chemicals. Mutagenesis 1996;11:363-81.
11. Jenkins GJS, Doak SH, Johnson GE, Quick E, Waters EM, Parry JM. Do dose response thresholds exist for genotoxic alkylating agents? Mutagenesis 2005;20:389-98.
12. Swain CG, Scott CB. Quantitative Correlation of Relative Rates. Comparison of Hydroxide Ion with Other Nucleophilic Reagents toward Alkyl Halides, Esters, Epoxides and Acyl Halides. J Am Chem Soc 1953;75: 141-7.
13. Beranek DT. Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mut Res 1990;231:11-30.
14. Op het Veld CW, Jansen J, Zdzienicka MZ, Vrieling H, van Zeeland AA. Methyl methanesulphonate-induced hprt mutation spectra in the Chinese hamster cell line CHO9 and its xrccl-deficient derivative EM-C11. Mut Res 1998;398:83-92.
15. Shelby MD, Tindall KR. Mammalian germ cell mutagenicity of ENU, IPMS and MMS, chemicals selected for a transgenic mouse collaborative study. Mut Res 1997;388:99-109.
16. Sbibuya T, Morimoto K. A review of the genotoxicity of 1-ethyl-1-nitrosourea. Mut Res 1993;297:3-38.
17. Singer B. In vivo formation and persistence of modified nucleosides resulting from alkylating agents. Environ Health Perspect 1985;62:41-8.
18. Crespi CL. Thilly G. Assay for gene mutation in a human lymphoblastoid line, AHH-1, competent for xenobiotic metabolism. Mut Res 1984;128:221-30.
19. Fenech M. The in vitro micronucleus technique. Mut Res 2000;455:81-95.
20. Furth EE, Thilly WG, Penman BW, Liber HL, Rand WM. Quantitative assay for mutation in diploid human lymphoblasts using microliter plates. Analyt Biochem 1981;110:1-8.
21. Osterman-Golkar S, Czene K, Lee MS, et al. Dosimetry by means of DNA and haemoglobin adducts in propylene oxide-exposed rats. Toxicol App Pharmacol 2003;191:245-54.
22. van Sittert NJ, Boogaard P, Natarajan AT, Tates AD, Ehrenberg LG, Tornqvist MA. Formation of DNA adducts and induction of mutagenic effects in rats following 4 weeks inhalation exposure to ethylene oxide as a basis for cancer risk assessment. Mut Res 2000;447: 27-48.
23. Zito R. Low doses and thresholds in Genotoxicity: from theories to experiments. J Exp Clin Cancer Res 2001;20:315-25.
24. Kirsch-Volders M, Aardema M, Elhajouji A. Concepts of thresholds in mutagenesis and carcinogenesis. Mut Res 2000;464:3-11.
25. Suter W, Brennand J, McMillan S, Fox M. Relative mutagenicity of antineoplastic drugs and other alkylating agents in V79 Chinese hamster cells, independence of cytotoxic and mutagenic responses. Mut Res 1980;73: 171-81.
26. Natarajan AT, Simons JWIM, Vogel EW, Vanzeeland AA. Aberrations, sister chromatid exchanges and point mutations induced by monofunctional alkylating agents in Chinese-hamster cells - a correlation with different ethylation products in DNA. Mut Res 1984;128:31-40.
27. Op het Veld CW, van Hees Stuivenberg S, van Zeeland AA, Jansen JG. Effect of nucleotide excision repair on HPRT mutations in rodent cells exposed to DNA ethylating agents. Mutagenesis 1997;12:417-24.
28. Tsujikawa L, Weinfield M, Reha-Krantz LJ. Differences in replication of a DNA template containing an ethyl phosphotriesters by T4 DNA polymerase and Escherichia coli DNA polymerase I. Nucleic Acid Res 2003;31:4965-72.
29. Lutz WK. Dose response relationship and low dose extrapolation in chemical carcinogenesis. Carcinogenesis 1990;11:1243-47.
30. Purchase IFH, Auton TR. Thresholds in chemical carcinogenesis. Regulatory Toxicol Pharmacol 1995;22: 199-205.
31. Glaab WE, Tindall KR, Skopek TR. Specificity of mutations induced by methyl methanesulphonate in mismatch repair deficient human cancer cell lines. Mut Res 1999;427:67-78.
32. Guttenplan JB. Mutagenesis by N-nitroso compounds: relationships to DNA adducts, DNA repair and mutational efficiencies. Mut Res 1990;233:177-87.
33. Veleminsky J, Osterman-Golkar S, Ehrenberg L. Reaction rates and biological action of N-methyl- and N-ethyl-nitrosourea. Mut Res 1970;10:169-74.
34. Jansen JG, De Groot AJL, Vanteijlingen CMM, et al. Formation and persistence of DNA adducts in pouch skin fibroblasts and liver tissue of rats exposed in vivo to the monofunctional alkylating agents N-methyl-nitrosourea or N-ethyl-nitrosourea. Mut Res 1994;307: 95-105.
35. Sudhakar S, Tew KD, Schein PS, Woolley PV, Smulson ME. Nitrosourea interaction with chromatin and effect on poly(adenosine disphostphate ribose) polymerase activity. Cancer Res 1979;39:1411-7.
36. Berkowitz EML, Silk H. Methylation of chromosomal DNA by 2 alkylating-agents differing in carcinogenic potential. Cancer Lett 1981;12:311-21.
37. Jansen JG, Vrieling H, Vanteijlingen CMM, Mohn GR, Tates AD, vanZeeland AA. Marked differences in the role of O-6-alkylguanine in HPRT mutagenesis in T-lymphocytes of rats exposed in-vivo to ethylmethanesulfonate, N-(2-hydroxyethyl)-N-nitrosourea, or N-ethyl-N- nitrosourea. Cancer Res 1995; 55:1875-82.
38. 7- methylguanine and O-6-methylguanine levels in DNA of while blood cells from cancer patients treated with dacarbazine. Biomarkers 1996;2:94-8.